Facilitating accurate and timely detection of Diabetic Peripheral Neuropathy in your patients
Facilitating accurate and timely detection of Diabetic Neuropathy in your patients
Neuropathy screening has been a challenge to clinicians for many years due to its often subtle symptoms and the need for specialized equipment and expertise.
- The monofilament test is recommended to assess the risk of foot ulceration, but it has low sensitivity in detecting early-stage neuropathy.2
- Vibration perception threshold (VPT) evaluation is a validated clinical method known for detecting early neuropathy cases.3
- Standard biothesiometers require storage space and a continuous power supply, limiting their use in primary care.
The Ayati Difference
Ayati’s advanced and robust diagnostic devices have been designed to help clinicians to rapidly screen for neuropathy in primary care settings.
Our Products
VIBRASENSE
Vibrasense is a handheld, portable device that is based on true sinusoidal technology. It detects neuropathy by quantifying the vibration perception threshold.
VIBRASENSE + T
Vibrasense + T is a quantitative sensory testing (QST) device that can detect neuropathy by measuring the vibration perception, hot perception and cold perception thresholds.
Our Impact
Testimonials
References:
1.Bus S, Netten J, Monteiro‐Soares M, Lipsky B, Schaper N. Diabetic foot disease: “The Times They are A Changin’ ”. Diabetes Metab Res Rev. 2020;36(S1). doi:10.1002/dmrr.3249
2. Wang F, et al. Diagnostic accuracy of monofilament tests for detecting diabetic peripheral neuropathy: a systematic review and meta-analysis. J Diabetes Res. 2017;2017:8787261. https:// doi. org/ 10. 1155/ 2017/ 87872 61.
3. Martin CL, et al. Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study. Diabetes Care. 2010 Dec;33(12):2635-41.